Breaking News Instant updates and real-time market news.

INFI

Infinity Pharmaceuticals

$1.86

0.06 (3.33%)

15:48
08/07/18
08/07
15:48
08/07/18
15:48

Infinity Pharmaceuticals reports Q2 EPS (12c), consensus (20c)

As of June 30, the company had cash and cash equivalents of $49.2M. "Excluding a potential $22M contingent payment in cash or stock from Verastem, we believe that our current cash and cash equivalents will be adequate to satisfy our capital needs through the third quarter of 2019 based on our current operational plans. Our estimate as to how long we expect our existing cash and cash equivalents to be able to continue to fund our operations is based on assumptions that may prove to be wrong, and we could use our available capital resources sooner than we currently expect. Further, changing circumstances, some of which may be beyond our control, could cause us to consume capital significantly faster than we currently anticipate," the company added.

  • 07

    Aug

INFI Infinity Pharmaceuticals
$1.86

0.06 (3.33%)

10/12/17
WELS
10/12/17
UPGRADE
Target $5
WELS
Outperform
Infinity upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jim Birchenough upgraded Infinity Pharmaceuticals to Outperform and raised his price target for the shares to $5.00 from $1.50. The upgrade follows the selection of IPI-549 monotherapy data as a late breaker oral presentation at the Society of Immunotherapy of Cancer annual meeting in early November. The data have a "reasonable likelihood" of proof-of-concept response rate, and with likely validation of tumor macrophage targeting in immunooncology and a unique mechanism of action, upside potential is not reflected in the current stock price, Birchenough tells investors in a research note.
10/12/17
10/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Delta Air Lines (DAL) upgraded to Outperform from In-Line at Imperial Capital with analyst Michael Derchin saying the company is likely to grow unit revenues in fiscal year 2018 due to pricing power in its key domestic hubs and improving international results. 2. Transocean (RIG) upgraded to Buy from Neutral at Citi with analyst Scott Gruber saying if an upturn is forthcoming, Transocean should outperform given a "diminution" of concern toward its balance sheet and more new contract catalysts. 3. Canadian Pacific (CP) upgraded to Overweight from Neutral at JPMorgan with analyst Brian Ossenbeck saying he sees a shift to stronger volume growth as the company laps contract losses and records some new contract wins. 4. Infinity upgraded to Outperform from Market Perform at Wells Fargo with analyst Jim Birchenough saying the IPI-549 monotherapy data have a "reasonable likelihood" of proof-of-concept response rate, and with likely validation of tumor macrophage targeting in immunooncology and a unique mechanism of action, upside potential is not reflected in the current stock price. 5. Kroger (KR) upgraded to Equal Weight from Underweight at Stephens with analyst Ben Bienvenu saying he believes the pursuit of strategic alternatives for the convenience store business has potential to unlock value and that the risk/reward is more balanced following the stock's recent pullback. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/31/18
GHSC
05/31/18
INITIATION
Target $4
GHSC
Buy
Infinity Pharmaceuticals initiated with a Buy at Seaport Global
Seaport Global analyst Corey Davis initiated Infinity Pharmaceuticals with a Buy and $4 price target. The analyst believes 2018 could be a "break-out" year with new data on its lead compound IPI-549 in combination with Opdivo for various tumor types with June 4 at ASXO form its "dose escalation" cohort, Q2 initial data from the "dose expansion" cohort, and more mature data from the "dose expansion" later in the year.
05/31/18
05/31/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Wyndham Hotels & Resorts (WH) initiated with a Buy at Jefferies and an Overweight at JPMorgan. 2. Nxt-ID (NXTD) initiated with a Buy at Euro Pacific. 3. Infinity Pharmaceuticals (INFI) initiated with a Buy at Seaport Global. 4. Edwards Lifesciences (EW) and Medtronic (MDT) were initiated with an Outperform at Raymond James. 5. Rollins (ROL) initiated with a Hold at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

WEX

Wex

07:01
11/21/18
11/21
07:01
11/21/18
07:01
Recommendations
Wex analyst commentary  »

Wex price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$191.34

-6.825 (-3.44%)

07:01
11/21/18
11/21
07:01
11/21/18
07:01
Downgrade
Goldman Sachs rating change  »

Goldman Sachs downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYMTF

Hyundai Motor

$0.00

(0.00%)

07:00
11/21/18
11/21
07:00
11/21/18
07:00
Periodicals
U.S. prosecutors probe Hyundai, Kia vehicle recalls, Reuters reports »

U.S. prosecutors are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:00
11/21/18
11/21
07:00
11/21/18
07:00
General news
Treasury Market Outlook: »

Treasury Market Outlook:…

GLOB

Globant

$50.46

-1 (-1.94%)

06:59
11/21/18
11/21
06:59
11/21/18
06:59
Conference/Events
Globant management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 02

    Dec

WYNN

Wynn Resorts

$100.98

-2.49 (-2.41%)

06:58
11/21/18
11/21
06:58
11/21/18
06:58
Recommendations
Wynn Resorts analyst commentary  »

Wynn Resorts shares set…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

EMITF

Elbit Imaging

$1.65

(0.00%)

06:57
11/21/18
11/21
06:57
11/21/18
06:57
Hot Stocks
Elbit Imaging announces sale of additional Elbit Medical shares »

Elbit Imaging announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$0.00

(0.00%)

06:54
11/21/18
11/21
06:54
11/21/18
06:54
Hot Stocks
Airbus appoints Michael Schollhorn COO for Airbus Commercial Aircraft »

Airbus has appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XHR

Xenia Hotels

$19.99

0.08 (0.40%)

, H

Hyatt

$69.10

-0.64 (-0.92%)

06:54
11/21/18
11/21
06:54
11/21/18
06:54
Hot Stocks
Xenia Hotels acquires Park Hyatt Aviara Resort, Golf Club & Spa for $170M »

Xenia Hotels (XHR)…

XHR

Xenia Hotels

$19.99

0.08 (0.40%)

H

Hyatt

$69.10

-0.64 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

DE

Deere

$138.49

-4.04 (-2.83%)

06:50
11/21/18
11/21
06:50
11/21/18
06:50
Earnings
Deere reports Q4 EPS $2.42, consensus $2.45 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

BBY

Best Buy

$63.54

1.35 (2.17%)

06:50
11/21/18
11/21
06:50
11/21/18
06:50
Recommendations
Best Buy analyst commentary  »

Best Buy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

EADSY

Airbus

$0.00

(0.00%)

, IFNNY

Infineon

$0.00

(0.00%)

06:49
11/21/18
11/21
06:49
11/21/18
06:49
Hot Stocks
Airbus appoints Dominik Asam as future CFO »

In the context of the…

EADSY

Airbus

$0.00

(0.00%)

IFNNY

Infineon

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNKO

Funko

$15.15

-0.03 (-0.20%)

06:47
11/21/18
11/21
06:47
11/21/18
06:47
Recommendations
Funko analyst commentary  »

Funko holiday off to a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTG

Entegris

$27.29

1.09 (4.16%)

06:45
11/21/18
11/21
06:45
11/21/18
06:45
Conference/Events
Entegris management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

06:45
11/21/18
11/21
06:45
11/21/18
06:45
General news
Breaking General news story  »

Week of 11/16 MBA…

GPS

Gap

$24.65

-0.79 (-3.11%)

06:43
11/21/18
11/21
06:43
11/21/18
06:43
Periodicals
Gap reviews whether to close hundreds of weaker locations, WSJ reports »

Gap is evaluating whether…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ECOM

ChannelAdvisor

$10.44

-0.12 (-1.14%)

06:42
11/21/18
11/21
06:42
11/21/18
06:42
Conference/Events
ChannelAdvisor management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 11

    Dec

TCEHY

Tencent

$0.00

(0.00%)

, SPOT

Spotify

$129.73

2.99 (2.36%)

06:37
11/21/18
11/21
06:37
11/21/18
06:37
Periodicals
Tencent Music Entertainment could push IPO until 2019, Reuters reports »

Tencent Music…

TCEHY

Tencent

$0.00

(0.00%)

SPOT

Spotify

$129.73

2.99 (2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$91.76

-0.33 (-0.36%)

06:36
11/21/18
11/21
06:36
11/21/18
06:36
Periodicals
United wins victory in Newark Airport fee dispute, WSJ reports »

The Federal Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

BGNE

BeiGene

$125.87

1.5 (1.21%)

06:36
11/21/18
11/21
06:36
11/21/18
06:36
Initiation
BeiGene initiated  »

BeiGene initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

  • 03

    Dec

NMHLY

NMC Health

$0.00

(0.00%)

06:34
11/21/18
11/21
06:34
11/21/18
06:34
Upgrade
NMC Health rating change  »

NMC Health upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$89.12

3.57 (4.17%)

06:33
11/21/18
11/21
06:33
11/21/18
06:33
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

AAPL

Apple

$177.10

-8.7 (-4.68%)

06:32
11/21/18
11/21
06:32
11/21/18
06:32
Periodicals
Apple in talks to provide veterans access to electronic health records, WSJ says »

Apple is in talks with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

SWGAY

Swatch Group

$0.00

(0.00%)

06:31
11/21/18
11/21
06:31
11/21/18
06:31
Downgrade
Swatch Group rating change  »

Swatch Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWGAY

Swatch Group

$0.00

(0.00%)

06:31
11/21/18
11/21
06:31
11/21/18
06:31
Downgrade
Swatch Group rating change  »

Swatch Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.